Conférences  >  Médecine & Soins de Santé  >  Cancérologie

Binaytara Foundation

The Best of Hematology and Breast Cancer 2025 conference in Boise is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer. Drawing insights from the 66th ASH Annual Meeting (ASH24) and the San Antonio Breast Cancer Symposium (SABCS24), the conference features expert presentations on recent research and its clinical implications.

Binaytara Foundation CME;     Email.: cme@binayfoundation.org

oncology, hematology, CME, Breast Cancer

Cleveland Clinic

The 17th Annual International Symposium on Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiosurgery (SRS) in Lake Buena Vista, Florida, will bring together world leaders in brain-, spine- and body-targeted stereotactic radiation modalities and techniques. Faculty and participants will have three days to discuss advances in the treatment of benign and malignant tumors involving multiple organ sites. A broad range of organ-specific technical and clinical experience will be presented with opportunities to interact with faculty and system vendors. Scientific abstracts will be solicited from attendees for poster presentation sessions.

Liz Eaton, Education Coordinator;     Tél.: [2164455431];     Email.: eatonl3@ccf.org

radiation treatment, SBRT, SRS, stereotactic radiation, neurosurgery, neurology, radiation oncology, medical physicists, stereotactic body radiosurgery

Formation médicale continue (FMC),    Radiologie, médecine nucléaire et radiothérapie

Binaytara Foundation

The Hawaii Gastrointestinal Cancers Summit is a CME-accredited event that brings together leading experts in gastrointestinal malignancies to provide a comprehensive review of current and emerging strategies for managing cancers of the gastrointestinal tract. This summit is designed to enhance participants' knowledge and competence in applying the latest practice-changing clinical data and expert recommendations to improve patient outcomes. The program will include in-depth discussions and analyses of the latest scientific advancements and key updates in gastrointestinal cancers, including gastroesophageal, hepatobiliary, pancreatic, neuroendocrine, and colorectal cancers. Expert faculty will contextualize the use of various therapeutic agents, exploring how to effectively integrate these treatments into patient care. Additionally, case presentations will be featured to address the management of complex and challenging cases.

Binaytara Foundation CME;     Email.: cme@binayfoundation.org

oncology, cancer, gastrointestinal cancer, CME

The European Association for Cancer Research (EACR)

This meeting will delve into the profound consequences cancer can have on the body’s usual functions, and the underlying mechanisms behind these systemic effects. The ultimate goal is to explore how we might manipulate these mechanisms to develop more effective cancer treatments and improve the quality of life of patients with advanced cancer. We’ll be covering a wide range of topics including alterations in peripheral tissue function and the metabolic and inflammatory changes they induce, immune system performance, and cancer cachexia. This conference will be relevant for anyone with an interest in cancer biology, inter-organ communication, the role of cytokines, chemokines, and hormones in cancer, as well as cancer-induced changes in behaviour and metabolism.

Join us online on 25 and 26 February to learn more about this fascinating topic! Submit your abstract before 13 January and register before 03 February to secure your place.

Conference Officer: Hannah Barrs;     Tél.: [N/A];     Email.: hannah.barrs@eacr.org

cancer research, oncology, cancer biology, immunology, cancer cachexia, inter-organ communication, liver function, muscle function, adipose tissue function, tissue function, metabolic changes, inflammatory changes, tumour metastasis, novel therapeutic interventions, cytokines, chemokines, hormones, cancer metabolism

Biologie,    Immunologie et Allergie

event lab. GmbH

The event will cover malignant and inflammatory pancreatic diseases, featuring presentations from international experts and junior researchers. It offers workshops, poster sessions, and opportunities for networking and collaboration.

A fee-based registration is required and can be made under the following link: https://eventlab.regasus.de/portal/standard/registration/personal

Conference office event lab. GmbH;     Tél.: [+49 (0)341 30 88 84-82];     Email.: KBornschein@eventlab.org

pancreatitis, endoscopy. pancreatitis surgery, pancreatic cystic lesions, neuroendocrine tumors

Gastro-entérologie,    Hépatologie

Deutsche Krebsgesellschaft und Deutsche Krebshilfe

The AEK Cancer Congress hosts around 500 participants. It is funded by the German Cancer Society and the German Cancer Aid and will be held in 2025 under the theme “Understanding and targeting metastatic cancer”. You will see that we have assembled a great line-up of outstanding speakers, who will cover multiple exciting topics of current biology, from basic mechanism to multi-omics approaches and new molecular and immune-therapies to overcome metastatic cancer disease.

Kongress- und Kulturmanagement GmbH - Frau Frederike Stumpf;     Email.: frederike.stumpf@kukm.de

Biologie moléculaire,    Cellules souches

Infonet

4th International Cancer Expo and Conference welcomes you as our guest to the City of Philadelphia, USA during March 06- 08, 2025. iCancer Conference 2025 has a theme "Innovations in Cancer Research".

Tél.: [06172752612];     Email.: jessie@icancerconference.org

Keywords: Conference, Cancer, oncology, Oncology - Medical, oncology meetings, Cancer Conference, Philadelphia, Breast cancer conference Cancer genes, Chemotherapy, Hypoxia, Sarcomas, Lung Cancer, Oral Cancer, Bladder Cancer, Skin Cancer, Hematology, Medical Imaging, Prognosis, Radiotherapy, clinical trials, Epidemiology, Breast cancer, Cancer, Geneticist, Immune system, Pathologist, Prosthesis, Thermography, X-ray, Biopsy,

CHI

For 3 decades, the Precision Med TRI-CON has served as the leading international meeting place for the diagnostics and precision medicine community. Join over a thousand international thought leaders to discuss the latest research, technologies, innovation and business models in implementing precision medicine, biomarkers and companion diagnostics, genomic medicine, and artificial intelligence; innovation and market access strategies for at-home diagnostics, point-of-care testing and molecular diagnostics for infectious diseases; liquid biopsy and advanced diagnostics for precision oncology, including multi-cancer early detection and minimal residual disease testing. Emerging implications of faster and cheaper sequencing, AI and digital tools, and spatial biology and single-cell multiomics in advancing precision medicine will be covered in 2025. The new track on precision medicine beyond oncology will cover applications in immunology, neurology, and metabolic diseases. Join us in sunny San Diego for the in-person networking and visionary and thought-provoking keynote discussions you’ve come to expect from the TRI-CON!

Tél.: [781.972.5400];     Email.: chi@healthtech.com

event lab. GmbH

Renommierte Experten aus ganz Deutschland präsentieren Neuigkeiten aus der Forschung, Diagnostik und Therapie der Hämatologie. Am Freitagabend erwartet die Teilnehmer ein spannender Überraschungsvortrag. Neben zahlreichen Vorträgen bietet die Veranstaltung auch Raum für anregende Diskussionen und den Austausch von Erfahrungen unter Kolleginnen und Kollegen. Die Veranstaltung ist Teil der Veranstaltungsreihe "Hämatologie Leipzig" der Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie des Universitätsklinikums Leipzig.

Kongressbüro der event lab. GmbH;     Tél.: [+49 341 308884 64];     Email.: haematologie-leipzig@eventlab.org

Infektiologie, Immuntherapie, Gentherapie

Hématologie,    Immunologie et Allergie

Verein fuer Leukaemieforschung und -Therapie e.V. Muenster together with Klinikum Großhadern, Munich,Germany

The symposium is taking place again in Munich, Germany, in-person from Sunday, March 16 until Wednesday, March 19, 2025. Additionally to the XI Main Sessions two free contributions sessions MS V (Poster session) and MS IX (Best of Free Contributions Session) will additionally deliver the possibility to all those who want to present their own research data in form of a free contribution and discuss their findings with the worldwide most renowned scientists and researchers in the field of acute leukemias. We therefore encourage all who are interested in actively participating in ISALXIX with a free contribution to submit their abstract(s). All accepted abstracts will be part of the open access ISALXIX supplement published in ANNALS OF HEMATOLOGY and in the Poster Viewing and Discussion Session (MSV). Abstract Submission Deadline: October 31, 2024.

Organizing Office Beate Buske-Kosel;     Tél.: [+49 160 615 1531];     Email.: info@acute-leukemias.de

MS I: Biology of Acute Leukemias MS II: Biology in Acute Leukemias MS III: Genetic and Molecular Characterization of AML: Novel Markers for Diagnosis and Prognosis MS IV: Novel Approaches and Targeted Therapies in AML MS VI: Risk adapted Therapy of AML MS VII: Biology and Treatment of APL MS VIII: MRD in Acute Leukemias: Methods and Clinical Applications MS X: Immunotherapy for Acute Leukemias MS XI: ALL: Biology and Treatment Strategies

The European Association for Cancer Research

This meeting will explore the burgeoning field of cancer persister cells, a rare subset of cells which have emerged over the last decade as a significant factor in cancer treatment failure. Unlike resistance cells, which harbour genetic alterations enabling survival despite therapy, persister cells exhibit transient drug tolerance through reversible, non-mutational mechanisms. Our conference on this topic will bring together investigators from across the world to delve into molecular mechanisms, therapeutic targets, and emerging clinical implications of cancer persister cells, fostering collaboration and community-building in this pivotal and rapidly growing area of research.

Email.: christopher.iliffe@eacr.org

cancer research, oncology, cancer persister cells, cancer resistant cells, non-genetic drug resistance, treatment response, treatment success, treatment failure, molecular mechanisms of resistance and persistence, novel study methodologies, targeting vulnerabilities within persister cells, clinical implications and applications

Pharmacologie et développement des médicaments,    Biologie moléculaire

ESMO - European Society for Medical Oncology

The ESMO Sarcoma and Rare Cancers Congress 2025 promises to be an excellent platform for the exchange of cutting-edge research, innovative therapeutic approaches, and collaborative discussions aimed at advancing this field of oncology. Mark your calendars for 20 – 22 March 2025, as we converge in the picturesque city of Lugano, Switzerland, renowned for its scenic beauty and vibrant culture. The ESMO Sarcoma and Rare Cancers Congress 2025 scientific and educational programme will delve into the latest developments in diagnosis, treatment modalities, biology, and molecular classification of rare solid tumours, offering attendees a comprehensive overview of the rapidly evolving landscape in this specialised area.

Meetings Operations team;     Tél.: [+41 91 97 31 946];     Email.: meetings@esmo.org

sarcoma, rare cancers, oncology, cancer treatment, precision medicine, immunotherapy, soft tissue sarcomas, bone sarcomas, clinical trials, multidisciplinary care, cancer research, pediatric oncology, advanced therapies, targeted therapy, patient care, innovative treatments, rare tumors, genetic profiling, cancer biomarkers, molecular oncology, survivorship, personalised medicine, global oncology, treatment guidelines, research collaborations, healthcare professionals, drug development, radiation oncology, surgical oncology

Biologie,    Biologie moléculaire

Binaytara Foundation

The Best of Hematology and Breast Cancer 2025 conference in Des Moines is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer. Drawing insights from the 66th ASH Annual Meeting (ASH24) and the San Antonio Breast Cancer Symposium (SABCS24), the conference features expert presentations on recent research and its clinical implications.

Binaytara Foundation CME;     Email.: cme@binayfoundation.org

oncology, hematology, breast cancer, CME

Fraunhofer Institute for Cell Therapy and Immunology IZI

The AAV Meeting is aimed at all researchers who intend to transfer innovative AAV technologies into the clinic. Together with renowned experts we will focus on pioneering research, bridging the gap from small scale to GMP manufacturing, quality by design, cryopreservation, regulatory and funding, as well as clinical application. Abstract submission is open until January 20, 2024. Participation is free of charge.

AAV, vector, gene therapy, precision medicine, CAR-T, manufacturing, GMP

Biologie moléculaire,    Immunologie et Allergie

Wiener Medizinische Akademie GmbH

The Immunotherapy of Cancer Conference (ITOC) is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges. ITOC is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Wolfgang Wilmanns Stiftung (WWS), the German Cancer Consortium (DKTK), the Central European Cooperative Oncology Group (CECOG), the Chinese American Hematologist and Oncologist Network (CAHON) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich. The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.

Catherine Tomek - Conference Manager;     Tél.: [+43 1 405 13 83 18];     Email.: itoc@wma.co.at

ITOC 11 Scientific Committee ​ Niroshana Anandasabapathy (Weill Cornell New York, NY, United States) Michael Bergmann (Medical University Vienna, Austria) Mascha Binder​ (Universitätsspital Basel, Switzerland) Tanja D. de Gruijl (Cancer Center Amsterdam, The Netherlands) Alexander Eggermont (Cancer Center Amsterdam, The Netherlands) Ulrich Jäger (Medical University of Vienna, Austria) Sebastian Kobold (Ludwig-Maximilians-Universität, Munich, Germany) Volkmar Nuessler (Munich, Germany) Johanna Olweus (Institute for Cancer Research, University of Oslo, Norway) Chong-Xian Pan (Harvard Medical School, Boston, MA, United States) Pedro Romero (Translational Tumor Immunology Group, University of Lausanne, Switzerland) José Saro (CMO LCB-Novimmune, Switzerland) Stefani Spranger (Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, United States) Marion Subklewe (Ludwig-Maximilians-Universität, Munich, Germany) Eric Tartour (Hopital Européen Georges-Pompidou, Paris, France) Christoph Zielinski (Medical University of Vienna, Austria)

Binaytara Foundation

The 2025 Nebraska Congress on Hematologic Malignancies: Recent Advances and Cellular Therapy is a CME-accredited, in-person hematology conference featuring leading hematology experts. Expert faculty will place recent updates into clinical context and discuss how the results may change the current standards of care for patients with benign and malignant hematologic disorders. This conference is designed to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in the field. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care.

Binaytara Foundation CME;     Email.: cme@binayfoundation.org

oncology, hematology, CME, cellular therapy, hematologic malignancies

The European Cancer and Oncology Congress, scheduled for April 14-15, 2025, in Rome, Italy, promises to be a pivotal event for professionals dedicated to advancing cancer research and treatment across Europe and beyond. This congress serves as a crucial platform for oncologists, researchers, clinicians, nurses, and allied healthcare professionals to exchange ideas, present cutting-edge research findings, and discuss the latest innovations in cancer diagnosis, treatment, and care.

Email.: cancer@c2presearch.com

Cancer, Oncology, Psycho-Oncology, Cancer Genomics and Epigenetics, Cancer Immunotherapy, Cancer Drug Market

Binaytara Foundation

The Summit on Cancer Health Disparities 2025 (SCHD25) is a premier annual event focused on addressing cancer health disparities. The conference serves to bridge research and practice, offering practical strategies to improve cancer care delivery and outcomes. SCHD25 will unite oncology professionals, researchers, policymakers, and other stakeholders looking to address factors contributing to cancer health disparities with evidence-based interventions..

Binaytara Foundation CME;     Email.: cme@binayfoundation.org

oncology, public health, cancer, cancer disparities, health disparities

Binaytara Foundation

The Alaska Hematology Oncology Conference is an accredited continuing education activity designed to improve the care of cancer patients by educating cancer care providers about precision-guided management in hematology and oncology. Regional and national experts in the field will share comprehensive insights into the actionable molecular variations seen in common cancers. The event's format is tailored to promote active learning, enhance knowledge retention, and encourage practitioners to apply fresh insights into their clinical routines. Through didactics, case-centric discussions, and lively Q&A sessions, attendees can gain clarity, address uncertainties, and interact with hematology and oncology experts. This conference aims to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in precision-guided management in hematology and oncology. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care.

Binaytara Foundation CME;     Email.: cme@binayfoundation.org

oncology, hematology, cancer, CME

The European Association for Cancer Research (EACR)

One of our most popular conferences, Defence is the Best Attack 2025 will be our fifth edition on this topic. Participants will learn about the most recent advances in the field of immunotherapy from the basic science to clinical studies, including the identification of novel targets. You will gain an improved understanding of the mechanisms of action of therapeutic interventions, and benefit from discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to immunotherapy.

Conference Officer: Hannah Barrs;     Email.: hannah.barrs@eacr.org

cancer research, oncology, immunotherapy, immune-oncology, molecular oncology, tumour-immune system interactions, novel therapeutic approaches, basic cancer research, clinical cancer research, treatment response biomarkers, intrinsic treatment resistance mechanisms, acquired treatment resistance mechanisms, immune checkpoints, microbioma, vaccines, immune cell therapies.

European Molecular Biology Organization (EMBO)

The i-Cancer Congress is a premier international event scheduled to take place in Toronto, Canada on May 26-27, 2025. This congress brings together leading experts, researchers, healthcare professionals, and industry leaders in the field of oncology to discuss and share the latest advancements in cancer research, treatment, and care. The i-Cancer Congress offers an unparalleled opportunity to stay updated on the latest trends and developments in oncology. Attendees will benefit from educational sessions, networking opportunities, and exposure to innovative solutions and technologies shaping the future of cancer treatment. This event is designed to enhance knowledge, foster collaboration, and inspire new approaches to combat cancer.

Tél.: [02032898567];     Email.: info@icancercongress.com

Cancer Research, Immunotherapy, Oncology, Clinical Research, Lung Cancer, Breast Health, Cancer Prevention and Early Detection, Supporting Cancer Patients and Survivors, Clinical Studies, Cancer Immunity and Immunotherapy, Precision Medicine and Cancer Treatment, Gynaecologic Cancer, Neuro-Oncology and Neurosurgical Oncologys

Kongress- und Kulturmanagement GmbH

Inter- und multidisziplinäre Diagnostik und Therapie im gesamten Bereich der gastrointestinalen Onkologie. Am Vortag: Masterclass für junge Kollegen: Ein Teilbereich der GI Onkologie wird anhand eines Falls von allen Seiten beleuchtet (Vortrag und Diskussion)

Tél.: [01520 3132647];     Email.: davida.drescher@konzeptext.de

Chirurgie,    Radiologie, médecine nucléaire et radiothérapie

Deutsche Gesellschaft für Radioonkologie e.V.

Der DEGRO 2025 richtet sich an Radioonkologen, Medizinphysiker, Strahlenbiologen, MTRAs und Studierende. Unter dem Motto „RADIOONKOLOGIE | TEAMWORK – Maßgeschneidert. Patientenzentriert. Zukunftsorientiert. Selbstbestimmt im Team“ liegt der Fokus auf der interdisziplinären Zusammenarbeit. Abstracts können eingereicht werden. Es werden Refresherkurse sowie Kurse zur Strahlenschutzverordnung angeboten. Weitere Themen: maßgeschneiderte Therapien und patientenzentrierte Ansätze.

Kongressorganisation;     Tél.: [+49 3643 2468-126];     Email.: degro-registrierung@kukm.de

Radioonkologie, Strahlentherapie, Nuklearmedizin, Medizinphysik, Strahlenbiologie, MTRAs, Strahlenschutzverordnung, interdisziplinäre Zusammenarbeit, Abstract-Einreichung, Refresherkurse

Radiologie, médecine nucléaire et radiothérapie,    Cours de radioprotection

Spectus meetings World

We are delighted to extend a warm greeting for the 2nd International Conference on Cancer and Oncology Research, (World Cancer 2025 ) which will be held in the famous city Barcelona, Spain on June 23-24, 2025, organized in coordination with generous support and cooperation from passionate academicians and organizing committee members with the theme “Raising Wings to Promote Cancer Free World".

Tél.: [1 302 308 5943];     Email.: worldcancer@spectusconferences.com

Conference Sessions Tumor heterogeneity and Cancer Metastasis Translational Biology to Medicine in Innovative oncology Immune Responses & DNA Repair - Cancer Fields Cancer Genetics Surgical Oncology Single-cell and Spatial Multiomics in Cancer Research Cancer Prevention & Research Cancer Signaling Next Generation Cancer Models Cancer Imaging Techniques Radiation Oncology Gynecologic Cancer Cancer treatment & palliative care Pediatric Oncology Cancer Immunology & Immunotherapy Breast cancer Computational Analysis of Cancer Nanopore Sequencing of Cancer Genomes Biomarkers in Cancer Organ-Defined Cancers The Application of Clinical Proteomics for Precision Oncology Drug Resistance in Cancer Cancer Genetics and Epigenetics Cancer Diagnostics: From Research to Clinical Practice Advanced Therapies in Cancer Cancer Diagnosis and Screening Cancer Science and Targeted Therapies Cancer Science and Therapeutics Organ Specific Cancer Pharmacology in Cancer AI in Cancer Control Tobacco control Cancer diagnosis and care

event lab. GmbH

Anlässlich des 28. Europäischen Hämatologen Kongresses werden bei EHA Kompakt in einer dreistündigen, digitalen Veranstaltung die Neuigkeiten des Kongresses der European Hematology Association anschaulich zusammengefasst. Ziel ist es, einen auf das Wesentliche fokussierten und interessanten Überblick zu den Schwerpunkten der Hämatologie zu geben. Dabei wird insbesondere auf klinisch relevante Innovationen im Fachgebiet gesetzt. Anschließend besteht der Raum für eine angeregte wissenschaftliche Diskussion über die neuen Erkenntnisse. Die Veranstaltung ist Teil der Veranstaltungsreihe "Hämatologie Leipzig" der Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie des Universitätsklinikums Leipzig. Weitere geplante Veranstaltungen unter: https://leipzig-haematologie.de/

Kongressbüro der event lab. GmbH;     Tél.: [+49 341 308884 64];     Email.: haematologie-leipzig@eventlab.org

Onkologie, Zelltherapie, Hämostaseologie, Immunologie, Infektiologie

Hématologie,    Immunologie et Allergie

Uniklinik Köln

After the great success of the 2nd Cologne Conference on Lung Cancer in 2019 we are again looking forward to an exciting meeting on cutting-edge translational research in lung cancer. At the conference, the world's best lung cancer researchers will discuss the current challenges in the diagnosis and treatment of lung cancer. Topics include early detection & prevention of lung cancer, intrinsic & extrinsic influences on tumor evolution, drug resistance & plasticity, next generation immunotherapy, mechanisms of metastasis, tumor-neuronal interactions, liquid biopsies and late breaking clinical trials update.

When: 26 & 27. June 2025

Email.: a.breuer@uni-koeln.de

lungcancer

Fusion

Laura Trundle, Director;     Email.: laura@fusion-conferences.com

DNA Damage Response, cancer biology, replication stress, cancer therapies, PARP inhibitors, BRCA, clinical development

Biologie moléculaire,    Génomique et bio-informatique

ESMO - European Society for Medical Oncology

This important event will bring together leading experts, researchers, and healthcare professionals dedicated to the advancement of gastrointestinal cancers treatment and care. Through groundbreaking presentations, multidisciplinary tumour boards, controversy sessions, and more, attendees will have the opportunity to delve into the latest research findings, innovative therapeutic strategies, and emerging technologies that are shaping the future of GI cancers treatment. The programme will cover a wide spectrum of topics, including molecular prevention, diagnosis, precision therapy, and patient-centered care approaches in the treatment of GI malignancies.

Meetings Operations team;     Tél.: [+41 (0)91 973 19 62];     Email.: GIcongress@esmo.org

molecular prevention, diagnosis, precision therapy, patient-centered care, multidisciplinary tumour boards, immunotherapy, molecular characterisation, early detection, innovative therapeutic strategies, emerging technologies, research methodology, policy and regulation, colorectal cancer, gastric cancer, gastroesophageal junction cancer, hepatocellular carcinoma, biliary tract cancer, pancreatic cancer, oesophageal cancer, anal cancer, neuroendocrine neoplasms

Gastro-entérologie,    Formation médicale continue (FMC)

Kongress- und Kulturmanagement GmbH

Der Kongress verspricht ein wissenschaftlich anspruchsvolles und interaktives Programm, das sämtliche Aspekte der Schlaganfallversorgung von der prästationären Phase bis zur Rehabilitation umfasst. Besonderen Wert wird daraufgelegt, alle in der Schlaganfallversorgung involvierten Fachdisziplinen zu repräsentieren und die neuesten Entwicklungen in der Schlaganfalltherapie zu präsentieren.

Kongress- und Kulturmanagement GmbH - Frau Svantje Hopf;     Email.: dsg-kongress@kukm.de

The European Association for Cancer Research (EACR)

The 6th edition of this conference will focus on cancer models that span in vitro investigations to in vivo cancer biology. It will emphasise how targeting the mechanisms that control tissue assembly – including the interactions with multiple epithelial cell types and the immune system – affects cancer progression and treatment response. Emerging topics also being discussed include mechanobiology, the immune response, how the extracellular matrix controls cell architecture, and how cell fate transitions underpin tissue morphogenesis and the metastatic cascade. The target audience for this conference is scientists, postdocs, and graduate students interested in the latest generation of engineered ex vivo models of tissue biology, in vivo cancer biology, and the use of these mechanobiological concepts for the development of cancer therapeutics. It will also be highly relevant for industry scientists interested in cutting-edge models of cancer and journal editors interested in ex vivo to in vivo models of biology and cancer.

Conference Officer Hannah Barrs;     Tél.: [N/A];     Email.: hannah.barrs@eacr.org

cancer research, oncology, in vitro models of cancer, ex vivo models of cancer, in vivo models of cancer, the extracellular matrix, cancer cell architecture, mechanobiology, immune response to cancer, tissue morphogenesis, the metastatic cascade, cancer immunotherapies, advanced imaging technologies, organoids, microtissue platforms, spatial transcriptomics, cell fate transitions, homeostasis, cancer progression, cancer therapeutic developments.

Biologie moléculaire,    Immunologie et Allergie

Nexovo Group

We are thrilled to invite you to the International Research Conference on Nursing & Healthcare, organized by Nexovo Group, set to take place on September 25-26, 2025, in the dynamic city of Dubai, UAE.

Nexovo Nursing 2025 will be a premier event designed to unite professionals, researchers, and thought leaders to delve into the latest developments and innovations in nursing and healthcare.

Tél.: [+91-8688033511];     Email.: Nursing@nexovoconferences.com

Arbeitsgemeinschaft Zervixpathologie und Kolposkopie e.V.

Programmschwerpunkte: • Update Zervixkarzinom-Screening, Kolposkopie – etabliertes diagnostisches Mittel für Zervix, Vulva, Vagina und perianal, Herausforderung Rio-Nomenklatur, Herausforderungen im Abklärungsalgorithmus, Wirkungen und Auswirkungen der HPV-Impfung,

Veranstalter: Frau Britta Eichler;     Email.: sekretariat@ag-cpc.de

Deutsche Gesellschaft für Neuroradiologie e.V. und Österreichische Gesellschaft für Neuroradiologie e.V.

Motto "NEURORADIOLOGIE BESSER MACHEN" = geprägt von Themen, wie der Rolle von wissenschaftlichem und klinischem Fortschritten und Unternehmergeist in der Neuroradiologie, Neuerungen in der Neurotraumatologie, neuen Indikationen und innovativen Techniken in der Neurointervention

Thematische Highlights: Neue Horizonte - the long shot, Neurointerventionen, Neurotraumatologie, Neue Arbeitswelt, Neuroonkologie, Neurodegeneration

Deutsche Gesellschaft für Neuroradiologie e.V. und Kongress- und Kulturmanagement;     Email.: dgnr@neuroradiologie.de und neurorad@kukm.de

Radiologie, médecine nucléaire et radiothérapie,    Neurologie

The European Association for Cancer Research (EACR) and The Mark Foundation for Cancer Research

Early-onset cancers are rising globally. Cancers typically associated with those over the age of 50 are increasingly being diagnosed in young adults. How to prevent and treat these tumours is still unknown. This conference aims to foster a deeper understanding of the biological mechanisms, risk factors, and clinical implications of early-onset cancers. By bringing together leading experts from diverse fields in cancer research, the meeting will provide a unique platform to discuss the latest discoveries about early-onset cancers, promoting interdisciplinary collaboration and identifying strategies for early detection, prevention, and treatment. Special attention will be given to knowledge gaps, translational studies and healthcare disparities, and towards improving the clinical management of early-onset cancer patients. The target audience for this conference is researchers and physicians who are interested in the epidemiology and aetiology of sporadic cancers among younger adults to discuss key questions in the field and lay the foundations for generating a community dedicated to the study of early-onset cancers.

Conference Officer, Hannah Barrs;     Tél.: [N/A];     Email.: hannah.barrs@eacr.org

cancer research, oncology, early-onset cancers, biological mechanisms of cancer, cancer risk factors, clinical implications, early detection, prevention, cancer treatment, cancer therapies, healthcare disparities, translational cancer research, clinical management of cancer patients, cancer epidemiology, cancer aetiology, molecular pathology, exposome changes, cancer microbiome, cancer immunity, the tumour microenvironment, carcinogenesis, cancer epigenetics, preclinical experimental models, microsimulation modelling, cancer, cancer survivorship.

Biologie moléculaire,    Biologie des systèmes

EMBL Heidelberg

This meeting will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. We aim to bring together scientists from across several disciplines connected with cancer research, for a unique opportunity to interact and stimulate further integration of these efforts.

EMBL Events;     Email.: events@embl.de

Mathews International LLC

The International Cancer Science and Research Conference 2025 scheduled for November 17-19, 2025, in Singapore, promises to be a pivotal event in the field of oncology. Held under the theme "Revolutionizing Cancer Care: Innovations and Collaborations for a Healthier Future," this hybrid event will welcome both onsite and virtual attendees, ensuring global accessibility. As one of the most anticipated Cancer Conferences of the year, it will unite leading oncologists, researchers, and healthcare professionals to advance the fight against cancer. This Oncology Conference will highlight ground breaking advancements in cancer prevention, diagnostics, and treatment, with key discussions focusing on areas such as immunotherapy, precision medicine, and targeted therapies. Participants in the Cancer Conferences 2025 will have the chance to share insights, foster collaborations, and explore innovative approaches to improving patient outcomes. Don’t miss this unparalleled opportunity to contribute to the future of cancer care—register now!

Tél.: [+13124624448];     Email.: cancer@mathewsconference.com

Cancer Conferences, Cancer Conferences 2025, Cancer Science and Research Conference, Oncology Conference, Radiology Conference, Oncology Conferences, Radiology Conferences, Oncology Events, Cancer Events, Oncology Conferences 2025, Cancer Congress, Cancer Hybrid Events, Cancer Webinars, Cancer Seminars, Cancer Meetings, Cancer Workshops, Cancer Virtual Conference, Cancer Symposium, Cancer Online Event, Cancer Hybrid Event, Cancer Summit, Cancer Expo, Upcoming Cancer Conference, International Cancer Conferences, Global Cancer Congress, Cancer Hybrid Webinar, Cancer Hybrid Seminar, International Conference on Cancer, Global Congress on Cancer, International Summit on Cancer, Cancer Seminar, Cancer Meeting, Cancer Workshop, Upcoming Cancer Congress, Upcoming Cancer Event, Cancer Event, Cancer Conference in USA, Cancer Congress in Europe, Cancer Meeting in Italy, Cancer Seminar in UK, Cancer Event in London, Cancer Workshop in Spain, Cancer Hybrid Event in Paris, Cancer Virtual conference in France, Top Cancer Conference, Top 10 Cancer Symposiums